涉嫌误导性陈述！向日葵遭浙江证监局立案，跨界半导体材料生变数

Core Viewpoint - The company Sunflower (300111) is under investigation by the Zhejiang Securities Regulatory Bureau for allegedly misleading statements in its restructuring plan, which has led to a significant drop in its stock price by 10.01% on January 14 [1][4][7]. Group 1: Restructuring Plan - Sunflower is planning to acquire 100% equity of Zhangzhou Xipu Materials Technology Co., Ltd. and 40% equity of Zhejiang Beid Pharmaceutical Co., Ltd. through a combination of issuing shares and cash payments [4][5]. - Xipu Materials focuses on the research, development, manufacturing, and sales of high-end semiconductor materials, including high-purity electronic special gases and silicon-based precursors, which are essential in semiconductor manufacturing processes [4][5]. - The restructuring plan has raised market concerns regarding the actual production capacity and business model of the target company, leading to a regulatory investigation [4][6]. Group 2: Regulatory Investigation - The Zhejiang Securities Regulatory Bureau has initiated an investigation into Sunflower due to potential misleading statements in the restructuring proposal, which could disrupt market order and harm investor interests [6][7]. - The Shenzhen Stock Exchange has issued a letter of concern regarding the actual production capacity of Xipu Materials' factories, requesting clarification on their operational status and financial performance [7]. - The investigation and the subsequent stock price drop indicate significant challenges for Sunflower's cross-industry acquisition plans, potentially affecting its reputation and market confidence [6][7].